[1]
Z. Hillel and Z. Alabady, “Targeting of CD38 and other NAD-dependent Enzymes in Leukemia Patients”, JBB, vol. 2, no. 2, pp. 26–33, Jun. 2023, doi: 10.57238/jbb.2023.6952.1036.